Steven Cohen acquired 523 Thousand Veracyte shares worth $15.5 Million. That's 0.05% of their equity portfolio (386th largest holding). The first Veracyte trade was made in Q1 2019. Since then Steven Cohen bought shares six more times and sold shares on eight occasions. The investor's estimated purchase price is $19.9 Million, resulting in a loss of 22%.